See you at the DIA Global Annual Meeting 2024!
Visit our Booth #2027
- Global Pharmacovigilance, Comprehensive Safety
- Risk Management and REMS
- Integrated Medical Information Services
- Integrated Regulatory Affairs and Medical Writing
- Quality Assurance and Compliance
Maximize regulator confidence, Optimize safety compliance
Enhance patient safety with our robust case processing, aggregate reporting, and signal management solutions. Increase regulator trust, and support market access through comprehensive, timely and accurate reporting while improving operational efficiency.
Mitigate risks with REMS and Risk Management
Unlock full market potential of your products by harnessing our expertise in developing Risk Management Plans (RMPs) and Risk Evaluation and Mitigation Strategies (REMS). Our strategic advice empowers you to navigate regulatory complexities across therapeutic modalities.Ā
Real-timeĀ Medical Information supportĀ to yourĀ Patients and HCPs
Provide best-in-class support to your patients and HCPs with our 24×7 integrated response center offering support in 100+ languages through customizable, end-to-end Medical Information services.
Improve drug development andĀ approval processes acrossĀ product life cycle
Strengthen your drug approval process and post-marketing surveillance across your portfolio by partnering with our team of experts who take complete ownership of Regulatory compliance, generating high-quality clinical and regulatory documents throughout the product life cycle.
Inspection Readiness with Unsurpassed Quality Assurance
Elevate your processes with our expertise in setting up a inspection-ready Quality Management System (QMS). Our meticulously developed risk-based programs ensures compliance and provides you with peace of mind at all times.
Your Trusted Partner
Brochures
Case Studies
Testimonials
I must commend the organizational skill, the professionalism, the clarity, the expertise on subject matter, execution excellence that APCER has exhibited in all my projects where I had collaboratedā¦
Medical Advisor, Medical Affairs
A leading bio-pharma companyMy experience with APCER has been excellent. The team was very helpful, knowledgeable, responsive and professional with all the work that was needed.
Global Clinical Leader
A leading pharmaceutical companyAPCER demonstrated extreme flexibility accommodating changes, and a number of last-minute changes were implemented quickly and correctly. I also appreciate the flexible communication during my workday, given the time zone differences between the APCER writers and myself.
Associate Submission Medical Writer
A leading bio-pharma companyAPCERās speed, responsiveness and flexibility to meet our safety needs is something we have always valued. APCER has helped harmonize our global pharmacovigilance operations and made us compliant with ever changing regulations.
Medical Director
US-based specialty pharmaceutical companyThe audit was carried out professionally and objectively. The scope of the audit was relevant and appropriate, and time efficient. The discussions during the audit were constructive and recommendations where helpful and appropriate. The team members involved in the audit had a positive experience and were made to feel at ease by the auditors.
QPPV and Pharmacovigilance Head
We are thankful to team APCER for bringing in strong practices & helping inspection readiness in our pharmacovigilance framework which led to successful FDA audits.
Senior Director
US-based pharmaceutical companyAPCERās invaluable support with Clinical trial disclosure deadlines helped us in timely submissions of periodic reports.
Head, Clinical Trial Transparency
Top 10 pharmaceutical company with operations in the EU and USWe appreciate APCER for its efficiency in responding to matters that they get even at the eleventh hour. Working with APCER has made compliance a lot easier.
AVP, Pharmacovigilance
US-based pharmaceutical companyWe are thankful to team APCER for bringing in strong practices & helping inspection readiness in our pharmacovigilance framework which led to successful FDA audits.
Senior Director
US-based pharmaceutical company